Dyne Therapeutics (DYN) Earnings Date, Estimates & Call Transcripts → The Hard Truth About Investing For Retirement (From Insiders Exposed) (Ad) Free DYN Stock Alerts $25.44 +0.57 (+2.29%) (As of 05:12 PM ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Earnings SummaryUpcoming Earnings DateMay. 9EstimatedActual EPS (Mar. 5) -$1.09 Missed By -$0.17 Consensus EPS (Mar. 5) -$0.92 Get Dyne Therapeutics Earnings AlertsEnter your email address below to receive the latest news and earnings results for DYN and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueDYN Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.DYN Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad TradeSmithThe A.I. story nobody is telling you (Read ASAP)There's been a lot of buzz surrounding A.I. over the past year... Most of it is just hype and speculation. But there's one recent A.I. development you NEED to hear about...Click here to see Louis' new video for yourself. Dyne Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20241($0.83)($0.83)($0.83)Q2 20241($0.83)($0.83)($0.83)Q3 20241($0.84)($0.84)($0.84)Q4 20241($0.84)($0.84)($0.84)FY 20244($3.34)($3.34)($3.34)DYN Earnings Date and InformationDyne Therapeutics last posted its quarterly earnings results on March 5th, 2024. The reported ($1.09) EPS for the quarter, missing the consensus estimate of ($0.92) by $0.17. Dyne Therapeutics has generated ($3.94) earnings per share over the last year (($3.94) diluted earnings per share). Earnings for Dyne Therapeutics are expected to grow in the coming year, from ($3.25) to ($3.14) per share. Dyne Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 9th, 2024 based off prior year's report dates.Read More Dyne Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 5/9/2024Estimated)------- 3/5/2024Q4 2023($0.92)($1.09)($0.17)($1.09)--10/30/2023Q3 2023($0.83)($0.99)($0.16)($0.99)--8/3/2023Q2 2023($0.81)($1.08)($0.27)($1.08)--5/11/2023Q1 2023($0.77)($0.78)($0.01)($0.78)--5/11/2023Q1 2023($0.77)($0.78)($0.01)($0.78)--5/11/2023Q1 2023($0.77)($0.78)($0.01)($0.78)-- Get the Latest News and Ratings for DYN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Dyne Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 5/11/2023Q1 2023($0.77)($0.78)($0.01)($0.78)--5/11/2023Q1 2023($0.77)($0.78)($0.01)($0.78)--5/11/2023Q1 2023($0.77)($0.78)($0.01)($0.78)--3/2/2023Q4 2022($0.84)($0.74)+$0.10($0.74)--3/2/2023Q4 2022($0.84)($0.74)+$0.10($0.74)--3/2/2023Q4 2022($0.84)($0.74)+$0.10($0.74)--3/2/2023Q4 2022($0.84)($0.74)+$0.10($0.74)--3/2/2023Q4 2022($0.84)($0.74)+$0.10($0.74)--3/2/2023Q4 2022($0.84)($0.74)+$0.10($0.74)--11/3/2022Q3 2022($0.95)($0.80)+$0.15($0.80)--11/3/2022Q3 2022($0.95)($0.80)+$0.15($0.80)--11/3/2022Q3 2022($0.95)($0.80)+$0.15($0.80)--11/3/2022Q3 2022($0.95)($0.80)+$0.15($0.80)--11/3/2022Q3 2022($0.95)($0.80)+$0.15($0.80)--11/3/2022Q3 2022($0.95)($0.80)+$0.15($0.80)--8/4/2022Q2 2022($0.79)($1.01)($0.22)($1.01)--8/4/2022Q2 2022($0.79)($1.01)($0.22)($1.01)--8/4/2022Q2 2022($0.79)($1.01)($0.22)($1.01)--8/4/2022Q2 2022($0.79)($1.01)($0.22)($1.01)--8/4/2022Q2 2022($0.79)($1.01)($0.22)($1.01)--8/4/2022Q2 2022($0.79)($1.01)($0.22)($1.01)--5/2/2022Q1 2022($0.88)($0.69)+$0.19($0.69)--5/2/2022Q1 2022($0.88)($0.69)+$0.19($0.69)--5/2/2022Q1 2022($0.88)($0.69)+$0.19($0.69)--5/2/2022Q1 2022($0.88)($0.69)+$0.19($0.69)--5/2/2022Q1 2022($0.88)($0.69)+$0.19($0.69)-- 5/2/2022Q1 2022($0.88)($0.69)+$0.19($0.69)--5/2/2022Q1 2022($0.88)($0.69)+$0.19($0.69)--3/10/2022Q4 2021($0.99)($1.00)($0.01)($1.00)--3/10/2022Q4 2021($0.99)($1.00)($0.01)($1.00)--3/10/2022Q4 2021($0.99)($1.00)($0.01)($1.00)--3/10/2022Q4 2021($0.99)($1.00)($0.01)($1.00)--3/10/2022Q4 2021($0.99)($1.00)($0.01)($1.00)--3/10/2022Q4 2021($0.99)($1.00)($0.01)($1.00)--Thousands of investors use this no cost solution | Do you? (Ad)In today’s volatile markets we are all looking for the edge. But imagine tapping into a world where every investment move has the potential to be ahead of the curve. Most investors have heard of the publication Insider Financial. For nearly a decade, they've unlocked doors to opportunities tucked away from the public eye, guiding over a million investors with well researched information before it hits the mainstream media.Simply tap here now to subscribe and start getting "Insider Financial Advantage"3/10/2022Q4 2021($0.99)($1.00)($0.01)($1.00)--11/4/2021Q3 2021($0.65)($0.83)($0.18)($0.83)--11/4/2021Q3 2021($0.65)($0.83)($0.18)($0.83)--11/4/2021Q3 2021($0.65)($0.83)($0.18)($0.83)--11/4/2021Q3 2021($0.65)($0.83)($0.18)($0.83)--11/4/2021Q3 2021($0.64)($0.83)($0.19)($0.83)--11/4/2021Q3 2021($0.65)($0.83)($0.18)($0.83)--11/4/2021Q3 2021($0.65)($0.83)($0.18)($0.83)--8/5/2021Q2 2021($0.55)($0.58)($0.03)($0.58)--8/5/2021Q2 2021($0.55)($0.58)($0.03)($0.58)--8/5/2021Q2 2021($0.55)($0.58)($0.03)($0.58)--8/5/2021Q2 2021($0.55)($0.58)($0.03)($0.58)--8/5/2021Q2 2021($0.55)($0.58)($0.03)($0.58)--8/5/2021Q2 2021($0.55)($0.58)($0.03)($0.58)--8/5/2021Q2 2021($0.55)($0.58)($0.03)($0.58)--5/6/2021Q1 2021($0.60)($0.50)+$0.10($0.50)--5/6/2021Q1 2021($0.60)($0.50)+$0.10($0.50)--5/6/2021Q1 2021($0.60)($0.50)+$0.10($0.50)--5/6/2021Q1 2021($0.60)($0.50)+$0.10($0.50)--5/6/2021Q1 2021($0.60)($0.50)+$0.10($0.50)--5/6/2021Q1 2021($0.60)($0.50)+$0.10($0.50)--5/6/2021Q1 2021($0.60)($0.50)+$0.10($0.50)-- Dyne Therapeutics Earnings - Frequently Asked Questions When is Dyne Therapeutics's earnings date? Dyne Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 9th, 2024 based off last year's report dates. Learn more on DYN's earnings history. Did Dyne Therapeutics beat their earnings estimates last quarter? In the previous quarter, Dyne Therapeutics (NASDAQ:DYN) missed the analysts' consensus estimate of ($0.92) by $0.17 with a reported earnings per share (EPS) of ($1.09). Learn more on analysts' earnings estimate vs. DYN's actual earnings. How much profit does Dyne Therapeutics generate each year? Dyne Therapeutics (NASDAQ:DYN) has a recorded net income of -$235.94 million. DYN has generated -$3.94 earnings per share over the last four quarters. What is Dyne Therapeutics's EPS forecast for next year? Dyne Therapeutics's earnings are expected to grow from ($3.25) per share to ($3.14) per share in the next year. More Earnings Resources from MarketBeat Related Companies: Rocket Pharmaceuticals Earnings Results TG Therapeutics Earnings Results Vera Therapeutics Earnings Results Geron Earnings Results Arvinas Earnings Results Rhythm Pharmaceuticals Earnings Results Amphastar Pharmaceuticals Earnings Results Maravai LifeSciences Earnings Results PTC Therapeutics Earnings Results Galapagos Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Taiwan Semiconductor Earnings: AI Dominance and Future OutlookCSX Co.: The Railroad Powering Ahead with an Earnings Beat What's Driving Tesla Lower Ahead of its Earnings?Blackrock vs. State Street: Earnings in a Volatile MarketWhat to Expect From the Q1 Earnings Reporting SeasonLululemon Stock Implodes Post Earnings, Guidance Muted Applied Optoelectronics earnings dumper, pain now for gain later? This page (NASDAQ:DYN) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersSHOCKING Crypto Leak…Crypto 101 Mediatop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingHow to camouflage a factory of 53,000 workersStansberry ResearchMan Who Predicted 2008: “This Will be Worse.”AltimetryExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersExposed: How Big Banks Plan to Chain Your Wealth with Digital DollarsGoldenCrest Metals Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dyne Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.